ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

R. Lee Clark Clinic Dedication To Honor M.D. Anderson’s “Architect”

November 13, 1987

Regulatory Agencies: FDA Proposes “Treatment IDE” Funding Opportunities:

February 7, 1997

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014

After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk

December 13, 2002

Nominations Sought for Disney-ACS Research Professor

November 19, 1993

CCOP Reponses So Far Indicates application To Total 150-200

August 27, 1982